Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
Clinical trial NCT05255666 · WITHDRAWN
Trial details
- NCT number
- NCT05255666
- Sponsor
- Washington University School of Medicine
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2027-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.